Levitee Competitors

Pink Sheets . USA . 
Stock . Levitee Labs
LVTTF Stock  USD 0  0.00  0.00%   
Analyzing Levitee Labs competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Levitee Labs to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Levitee Labs Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Levitee Labs competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Levitee Labs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.0000.00
Details
Intrinsic
Valuation
LowRealHigh
0.0000.00
Details
Naive
Forecast
LowNextHigh
000
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
000
Details

Levitee Labs Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Levitee Labs and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Levitee and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Levitee Labs does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
CBDNF
+ 0.63
AQSZF
AQSZF
+ 0.58
MGCLF
CBDNF
+ 0.54
MGCLF
FLHLF
+ 0.36
AQSZF
FLHLF
+ 0.34
MGCLF
FLHLF
+ 0.27
CBDNF
  
High negative correlations   
BCBCF
- 0.61
CBDNF
SFWJ
- 0.57
AQSZF
BCBCF
- 0.51
MGCLF
BCBCF
- 0.41
FLHLF
BCBCF
- 0.32
AQSZF
ANTCF
- 0.31
MGCLF

Risk-Adjusted Indicators

There is a big difference between Levitee Pink Sheet performing well and Levitee Labs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Levitee Labs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
SKYI  14.90  3.89  0.09  3.83  14.21 
(58.66)
 41.67 
(40.00)
 212.75 
MGCLF  1.17 (0.51) 0.00 (0.38) 0.00 
 0.00 
 0.00 
(3.70)
 29.91 
CBDY  10.85  1.59  0.07 (1.15) 12.04 
(16.37)
 38.10 
(25.00)
 83.33 
AQSZF  2.82 (0.87) 0.00  1.88  0.00 
 0.00 
 2.22 
(10.64)
 45.35 
CBDNF  3.63 (0.23) 0.00  0.62  0.00 
 0.00 
 14.75 
(13.33)
 47.67 
FLHLF  11.45  1.65  0.09 (1.47) 12.24 
(16.58)
 27.12 
(21.33)
 91.17 
SFWJ  11.87  1.43  0.06 (1.17) 13.54 
(19.11)
 39.13 
(27.27)
 174.89 
BCBCF  19.36  8.18  0.23 (29.93) 9.94 
(98.78)
 10.89 
(13.07)
 425.33 
AXRX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
ANTCF  24.33  4.86  0.00  0.26  0.00 
 0.00 
 76.99 
(48.53)
 451.80 
All Fundamental Data

Levitee Labs Competitive Analysis

The better you understand Levitee Labs competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Levitee Labs' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Levitee Labs' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
LVTTF SKYI MGCLF CBDY AQSZF CBDNF FLHLF SFWJ BCBCF AXRX
 0.00 
 0 
Levitee
 41.67 
 0 
Sky
 0.00 
 0.21 
MGC
 5.00 
 0 
Target
 7.04 
 0.01 
Aequus
 0.00 
 0.06 
CBD
 31.33 
 0.04 
Filament
 27.78 
 0.01 
Software
 10.61 
 0.05 
BCBCF
 0.00 
 0 
Amexdrug
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Very steady
Out of control
Out of control
Very steady
Out of control
Out of control
Out of control
Very steady
Market Performance
(90 Days Performance)
Very Weak
OK
Very Weak
Modest
Very Weak
Very Weak
OK
Modest
Good
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Quite High
Above Average
Dangerous
Above Average
Low
Dangerous
Below Average
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Not Rated
Strong Sell
Strong Sell
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
N/A
N/A
0.84
0.17
0.78
0.09
4.1
N/A
6.38
1.35
Net Asset
12.97 M
N/A
22.6 M
13.06 M
4.35 M
2.09 M
17.84 M
N/A
1.95 M
2.31 M
Profit Margin
N/A
N/A
N/A
N/A
-1.36
N/A
N/A
N/A
-1.96
0.0181
EBITDA
(10.73 M)
N/A
(16.44 M)
2.23 M
(1.23 M)
(4.6 M)
(9.08 M)
N/A
(2.83 M)
380.83 K
Current Valuation
2.27 M
22 M
24.97 M
4.2 M
3.03 M
14.44 M
7.57 M
N/A
1.82 M
34.51 M
Price To Book
0.0903
N/A
5.69
7.83
32.78
N/A
0.85
N/A
3.14
51.38
Operating Margin
N/A
N/A
-3.28
N/A
-1.31
-2.71
-31.94
N/A
-1.82
0.0361
Retained Earnings
N/A
N/A
N/A
N/A
(5.72 M)
N/A
N/A
N/A
N/A
961 K
Current Asset
N/A
N/A
N/A
N/A
458 K
N/A
N/A
N/A
N/A
1.76 M
Beta
N/A
2.37
1.23
-0.51
0.44
0.49
N/A
234.21
N/A
-0.72
Number Of Employees
9
1
16
61
14
2
11
2
4
9
Shares Outstanding
100.42 M
110.02 M
2.87 B
617.03 M
132.63 M
49.46 M
174.95 M
N/A
53.02 M
169.11 M
Cash Flow From Operations
(4.63 M)
(12.55 K)
(12.16 M)
100.12 K
(1.17 M)
(1.14 M)
(5.41 M)
N/A
(875.7 K)
27.49 K
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
N/A
33.67 K
4.35 M
1.72 M
26.09 K
1.34 M
868.91 K
N/A
94.47 K
961.12 K
Return On Equity
N/A
N/A
-2.19
-23.05
-2.92
N/A
-0.4
N/A
-0.32
0.29
Z Score
N/A
N/A
1.8
0.6
93.4
-4.2
5.4
N/A
21.9
14.2
Return On Asset
N/A
N/A
-0.45
-0.0596
-0.42
-1.38
-0.21
N/A
-0.18
0.11
Book Value Per Share
N/A
N/A
0.002
-0.005
-0.003
-0.26
0.084
N/A
0.022
0.004
Current Liabilities
N/A
N/A
N/A
N/A
704 K
N/A
N/A
N/A
N/A
798 K
Total Asset
12.97 M
N/A
22.6 M
13.06 M
4.35 M
2.09 M
17.84 M
N/A
1.95 M
2.31 M
Debt To Equity
N/A
N/A
0.84
1.82
1.39
N/A
0.059
N/A
0.066
1.46
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
1.5
N/A
N/A
N/A
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
N/A
6.12
N/A
N/A
N/A
0.18
N/A
N/A
N/A
Market Capitalization
401.67 K
22 M
17.2 M
2.47 M
4.12 M
5.93 M
8.08 M
N/A
4.03 M
16.91 M
Price To Earning
N/A
N/A
N/A
N/A
-1.79
N/A
N/A
N/A
N/A
165.0
Price To Sales
0.053
N/A
5.81
340.13
1.44
2.79
103.44
N/A
4.63
3.04
Net Income
(11.4 M)
(13.77 K)
(20.35 M)
272.88 K
(1.81 M)
(5.25 M)
(9.25 M)
N/A
(2.86 M)
111.36 K
Earnings Per Share
N/A
N/A
-0.005
N/A
-0.01
-0.11
-0.042
N/A
N/A
N/A
Shares Owned By Insiders
37.49
N/A
9.1
11.37
14.96
26.61
66.23
N/A
66.39
N/A
Revenue
1.72 M
N/A
4.65 M
N/A
2.71 M
166.95 K
N/A
N/A
151
10.43 M
Working Capital
N/A
N/A
N/A
N/A
(246 K)
N/A
N/A
N/A
N/A
966 K
Cash And Equivalents
N/A
N/A
1.89 M
114.21 K
1.39 M
59.92 K
3 M
N/A
740.29 K
168.01 K
Cash Per Share
N/A
N/A
N/A
N/A
0.01
N/A
0.02
N/A
0.02
N/A
Gross Profit
N/A
N/A
562.87 K
5 K
2.69 M
3.61 K
N/A
N/A
(983)
1.01 M
Day Typical Price
0.0027
0.0034
0.21
0.0021
0.0066
0.06
0.0386
0.013
0.0455
0.002
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
N/A
0.0635
N/A
N/A
N/A
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
N/A
0.0025
N/A
N/A
N/A
Daily Balance Of Power
0.0
9.2 T
0.0
9.2 T
(9,223,372,036,855)
0.0
3.76
(9,223,372,036,855)
(9,223,372,036,855)
0.0
Period Momentum Indicator
N/A
0.001
N/A
1.0E-4
(0.0005)
N/A
0.0094
(0.01)
(0.01)
N/A
Rate Of Daily Change
1.0
1.42
1.0
1.05
0.93
1.0
1.31
0.72
0.89
1.0
Day Median Price
0.0027
0.0034
0.21
0.0021
0.0066
0.06
0.0382
0.013
0.0455
0.002
Price Action Indicator
N/A
5.0E-4
N/A
1.0E-4
(0.0003)
N/A
0.006
(0)
(0)
N/A
Relative Strength Index
N/A
55.39
24.12
47.49
22.93
42.0
51.91
42.43
71.32
N/A
Coefficient Of Variation
N/A
834.13
(865.51)
1107.91
(744.88)
(2,499)
1053.85
1727.24
712.84
N/A
Mean Deviation
N/A
14.9
1.17
10.85
2.82
3.63
11.45
11.87
19.36
N/A
Jensen Alpha
N/A
3.89
(0.51)
1.59
(0.87)
(0.23)
1.65
1.43
8.18
N/A
Total Risk Alpha
N/A
(1.27)
(0.90)
(1.09)
(2.01)
(1.40)
(1.02)
(2.26)
(1.01)
N/A
Sortino Ratio
N/A
0.0889
N/A
0.0703
N/A
N/A
0.087
0.056
0.2254
N/A
Downside Variance
N/A
1922.8
N/A
353.48
N/A
N/A
260.42
441.34
1269.17
N/A
Standard Deviation
N/A
33.59
3.26
16.09
6.87
7.02
16.17
22.58
58.16
N/A
Kurtosis
N/A
17.16
32.44
1.7
25.6
4.24
0.9774
17.84
35.88
N/A
Potential Upside
N/A
41.67
N/A
38.1
2.22
14.75
27.12
39.13
10.89
N/A
Treynor Ratio
N/A
3.83
(0.38)
(1.15)
1.88
0.6214
(1.47)
(1.17)
(29.93)
N/A
Maximum Drawdown
N/A
212.75
29.91
83.33
45.35
47.67
91.17
174.89
425.33
N/A
Variance
N/A
1128.54
10.6
259.0
47.14
49.28
261.52
509.68
3382.67
N/A
Market Risk Adjusted Performance
N/A
3.84
(0.37)
(1.14)
1.89
0.6314
(1.46)
(1.16)
(29.92)
N/A
Risk Adjusted Performance
N/A
0.1014
(0.08)
0.0785
(0.09)
(0.02)
0.0821
0.0539
0.1171
N/A
Skewness
N/A
3.5
(4.78)
0.7213
(3.66)
0.1487
0.3176
3.15
5.8
N/A
Semi Deviation
N/A
14.21
N/A
12.04
N/A
N/A
12.24
13.54
9.94
N/A
Information Ratio
N/A
0.116
(0.16)
0.0822
(0.15)
(0.06)
0.0868
0.0521
0.138
N/A
Value At Risk
N/A
(40.00)
(3.70)
(25.00)
(10.64)
(13.33)
(21.33)
(27.27)
(13.07)
N/A
Expected Short fall
N/A
(58.66)
N/A
(16.37)
N/A
N/A
(16.58)
(19.11)
(98.78)
N/A
Downside Deviation
N/A
43.85
N/A
18.8
N/A
N/A
16.14
21.01
35.63
N/A
Semi Variance
N/A
201.91
N/A
145.08
N/A
N/A
149.91
183.41
98.77
N/A

Levitee Labs Competition Performance Charts

Five steps to successful analysis of Levitee Labs Competition

Levitee Labs' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Levitee Labs in relation to its competition. Levitee Labs' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Levitee Labs in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Levitee Labs' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Levitee Labs, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Levitee Labs position

In addition to having Levitee Labs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Target Outcome ETFs Thematic Idea Now

Target Outcome ETFs
Target Outcome ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 93 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Levitee Pink Sheet

Levitee Labs financial ratios help investors to determine whether Levitee Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Levitee with respect to the benefits of owning Levitee Labs security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY